🇧🇪 Belgium Country × Condition
breast cancer Clinical Trials in Belgium
Active clinical trials for breast cancer with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 9 // Recruiting: 9 Phases: Phase 3, Phase 4 // Updated: Daily
Total Trials
9
Recruiting Now
9
Country
🇧🇪 Belgium
Active Trials in Belgium (9)
NCT07781306
Recruiting
PrOspEctive Metastases Imaging (POEM)
Enrollment
50 pts
Country
🇧🇪 Belgium
Cancer Research Antwerp
View Trial → NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Enrollment
2,250 pts
Country
🇧🇪 Belgium
Greenwich LifeSciences, Inc.
View Trial → NCT06274515 Phase 4
Recruiting
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
Enrollment
320 pts
Country
🇧🇪 Belgium
Hoffmann-La Roche
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇧🇪 Belgium
UMC Utrecht
View Trial → NCT06146231
Recruiting
Motiva Flora® Aesthetic Breast Recon® Clinical Study
Enrollment
66 pts
Country
🇧🇪 Belgium
Establishment Labs
View Trial → NCT06462963
Recruiting
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Enrollment
302 pts
Country
🇧🇪 Belgium
European Organisation for Research ...
View Trial → NCT07062965 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Enrollment
400 pts
Country
🇧🇪 Belgium
Pfizer
View Trial → NCT05768139 Phase 1, Phase 2
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Enrollment
880 pts
Country
🇧🇪 Belgium
Eli Lilly and Company
View Trial → NCT04690439
Recruiting
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
Enrollment
104 pts
Country
🇧🇪 Belgium
Jessa Hospital
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in Belgium?
There are currently 9 active clinical trials for breast cancer with sites in Belgium, of which 9 are actively recruiting patients.
How can I join a breast cancer clinical trial in Belgium?
To join a breast cancer clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Belgium?
Active breast cancer trials in Belgium span Phase 3, Phase 4, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology